UBS lowered the firm’s price target on Novonesis (NVZMY) to DKK 455 from DKK 460 and keeps a Neutral rating on the shares.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks